Capacity building awards in integrative mammalian biology

Co-funders

HEFCE
MRC
SFC
British Pharmacological Society Integrative Pharmacology Fund:

AstraZeneca
GlaxoSmithKline
Pfizer

Health Technologies Knowledge Transfer Network (on behalf of BIS)

Funding total

£12M

Number of projects funded

4

Purpose

To build and consolidate best practice in integrative mammalian biology research in the UK.

Key aims

To provide ‘springboard’ funding to enhance high quality research and training in integrative mammalian biology
To provide seed corn funding to enhance the HEI’s strategy in integrative mammalian biology

Contact

Louisa Jenkin
louisa.jenkin@bbsrc.ac.uk
tel: 01793 413352
fax: 01793 413234